Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael Desgagné
Observed names:
Desgagné, Michael,
Michael Desgagné
Institutions:
Université de Sherbrooke,
Institut de pharmacologie de Sherbrooke,
Institut de recherche sur le cancer de l'Université de Sherbrooke,
Massachusetts Institute of Technology
Observed institutions:
Université de Sherbrooke,
Institut de pharmacologie de Sherbrooke,
Institut de recherche sur le cancer de l'Université de Sherbrooke,
Massachusetts Institute of Technology
ORCID:
0000-0002-0671-6283
Observed ORCID:
0000-0002-0671-6283
OpenAlex ID:
A5079493701
Works
29
Awards
4
The Therapeutic Value of Solanum Steroidal (Glyco)Alkaloids: A 10-Year Comprehensive Review
2023
·
Julien A. Delbrouck
, Michael Desgagné
, et al.
·
Molecules
·
64
PDF
Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic
2021
·
Magali Chartier
, Michael Desgagné
, et al.
·
Journal of Medicinal Chemistry
·
28
Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog
2021
·
Magali Chartier
, Michael Desgagné
, et al.
·
Biomedicine & Pharmacotherapy
·
23
Learning Universal Representations of Intermolecular Interactions with ATOMICA
2025
·
Ada Fang
, Michael Desgagné
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
22
PDF
Opening the amino acid toolbox for peptide‐based NTS2‐selective ligands as promising lead compounds for pain management
2022
·
Santo Previti
, Michael Desgagné
, et al.
·
Journal of Peptide Science
·
17
PDF
Optimizing Fecal Occult Blood Test (FOBT) Colorectal Cancer Screening Using Gut Bacteriome as a Biomarker
2023
·
Moumita Roy Chowdhury
, Karina Gisèle Mac Si Hone
, et al.
·
Clinical Colorectal Cancer
·
13
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
2024
·
Michael Desgagné
, Magali Chartier
, et al.
·
Angewandte Chemie International Edition
·
12
Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the science
2024
·
Émile Breault
, Michael Desgagné
, et al.
·
Pharmacological Research
·
11
PDF
Rational In Silico Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 Subpocket
2024
·
Michael Desgagné
, Antoine Désilets
, et al.
·
Journal of Medicinal Chemistry
·
9
PDF
Insights on Structure–Passive Permeability Relationship in Pyrrole and Furan-Containing Macrocycles
2024
·
Huy M. Ly
, Michael Desgagné
, et al.
·
Journal of Medicinal Chemistry
·
8
PDF
A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor
2025
·
Rebecca L. Brouillette
, Christine E. Mona
, et al.
·
Pharmacological Research
·
6
Efficient Fmoc-Protected Amino Ester Hydrolysis Using Green Calcium(II) Iodide as a Protective Agent
2022
·
Renaud Binette
, Michael Desgagné
, et al.
·
Molecules
·
6
PDF
Diversity-oriented synthesis of second generation guanidinium-rich transporters toward cell-selective penetration
2024
·
Duc Tai Nguyen
, Michael Desgagné
, et al.
·
Bioorganic Chemistry
·
5
Signaling Modulation via Minimal C-Terminal Modifications of Apelin-13
2023
·
Léa Théroux
, Robin Van Den Hauwe
, et al.
·
ACS Pharmacology & Translational Science
·
5
PDF
ATOMICA
2026
·
Fang, Ada
, Desgagné, Michael
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
·
1
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
2024
·
Michael Desgagné
, Magali Chartier
, et al.
·
Angewandte Chemie
·
1
On-resin Heck coupling enables small-molecule ligand discovery with covalent peptide-encoded libraries
2026
·
Ching-Pei Hsu
, Michael Desgagné
, et al.
·
Chemical Science
Chemical Determinants of Spinal Analgesia in NTS2-Selective Macrocycles
2026
·
Michael Desgagné
, Nathan Meneboo
, et al.
·
Journal of Medicinal Chemistry
PDF
TMPRSS6 Cleavage of β-Klotho Modulates FGF19 Signaling
2026
·
Matthieu Lepage
, Antoine Désilets
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Beyond arginine count: Rational engineering of amphipathic macrocyclic CPPs with enhanced intracellular delivery and endosomal escape
2026
·
Duc Tai Nguyen
, Michael Desgagné
, et al.
·
European Journal of Medicinal Chemistry Reports
PDF
StereoPep: Do Molecular Models Understand Stereochemistry? A Benchmark on Synthetic Diastereomeric Peptides
2026
·
Michael Desgagné
, Amirabbas Kazeminia
, et al.
·
ChemRxiv
Improved brain penetration of neurotensin(8–13) via blood-brain barrier shuttle conjugation underlies strong analgesia
2026
·
Camille Lagard
, Jérôme Côté
, et al.
·
Biomedicine & Pharmacotherapy
StereoPep
2026
·
Amirabbas Kazeminia
, Michael Desgagné
·
Hugging Face
Covalent Peptide-Encoded Libraries Enable Discovery of Inhibitors of Epidermal Growth Factor Receptor (EGFR)
2026
·
Ching-Pei Hsu
, Michael Desgagné
, et al.
·
ChemRxiv
PDF
Orthogonal Cleavage of the HMPB Linker from Solid Support Using HFIP
2025
·
Michael Desgagné
, Dennis A. Kutateladze
, et al.
·
Organic Letters
Show more works
View as search
Works count:
29
Citation count:
231
H-index:
9
I10-index:
8
Year
Topic
Type